Infighting and Legal Challenges Threaten eVTOL Breakthrough Despite Program Validation CAPR Q1 2026 Earnings WiderthanExpected Loss Drives Stock Higher on Steady Clinical Progress Trainline Upgrades FullYear Guidance for Second Time in 2026 Citing Strong Momentum